Abstract
Spleen cells that are cultured with interleukin 2 for as short a time as 4 days develop the ability to lyse syngeneic natural killer-resistant tumor cells but not to lyse syngeneic lymphoblasts. When mice were subjected to partial hepatectomy (HEP), the spleen cells exhibited not only an augmentation of natural killer activity, but also an augmentation ofin vitro induction of lymphokine activated killer (LAK) cells. Furthermore, the LAK cells exhibited lytic activities against syngeneic lectin-induced lymphoblasts and regenerating liver cells. The sensitivity of regenerating liver cells to lysis by LAK cells was detected as early as one day after HEP, and continued until day 14. Analysis by cell depletion techniques using monoclonal antibodies and complement, as well as discontinuous gradient sedimentation, indicated that the LAK cells activated by HEP were Thy-1+, Lyt-2+, asialo GM1+ and Lyt-1−, lymphocytes with a low density. After the intravenous (i.v.) administration of anti-asialo GM1 before HEP, thein vitro induction of LAK cells was remarkably inhibited.
Similar content being viewed by others
References
Saunders SJ, Hichma R, Macdonald R, Terblanche J. The treatment of acute liver failure. In: Popper H, Schaffner, F eds. Progress in liver disease, Vol. 4. New York and London: Grune & Strattoh, 1972; 333.
Lin TY, Chen, CC. Metabolic function and regeneration of cirrhotic and non-cirrhotic livers after hepatic lobectomy in man. Ann Surg 1965; 162: 959–972.
Makowka L, Falk RE, Falk JA, Teodorezyk-Injeya T, Ventur D, Rotstein LE, Falk W, Langer B, Blendis LM, Phillips T. The effect of liver cytosol on hepatic regeneration and tumor growth. Cancer 1983; 51: 2181–2190.
Craddock, CG, Nakai FS, Fukuta H, Vanslager LM. Proliferative activity of the lymphatic tissues of rats as studied with tritium-labeled thymidine. J Exp Med 1964; 120:389–412.
Sakai A, Tanaka S. Liver and immune responses V: Regenerating liver cells activates syngeneic lymphocytes. Cell Differentiation 1979; 8: 285–290.
Miyahara S, Yokomuro K, Takahashi H, Kimura Y. Regeneration and the immune system. I.In vitro andin vivo activation of lymphocytes by liver regeneration and the role of Kupffer cells in stimulation. Eur J Immunol 1983; 13: 878–883.
Sakai A, Pfeffermann R, Kountz SL. Liver regeneration and lymphocyte activation. Surg Gynecol Obstet 1976; 143: 914–918.
Higgins GM, Anderson RM. Experimental pathology of the liver: I. Restoration of the liver of the white rat following partial surgical removal. Arch Pathol 1931; 12: 186–202.
Sato H, Essnev E, Belkin M. Experiments on an ascites hepatoma III. The conversion of mouse hepatomas into the ascites form. J Nat Cancer Inst 1956; 17: 1–21.
Hamasaki M. On the properties of an established cell strain, JTC-11, from Ehrlich ascites tumor in tissue culture Part 1. The characteristics of the standard strain (K-strain) Okayama-Igakkai-Zasshi 1964; 76: 1–11. (in Japanese)
Seglen PO. Preparation of isolated rat liver cells. Methods Cell Biol 1976; 13: 29–83.
Willtrout RM, Mathieson BJ, Talmadge JE, Reynolds CW, Zhang S-R, Herberman RB, Ortaldo JR. Augmentation of organ-associated natural killer activity by biological response modifiers. Isolation and characterization of large granular lymphocytes from the liver. J Exp Med 1984; 160 1431–1449.
Cantrell DA, Smith KA. Transient expression of interleukin 2 receptors. Consequences for T cell growth. J Exp Med 1983; 158: 1895–1911.
Smith KA, Favata MF, Oroszlan S. Production and characterization of monoclonal antibodies to human interleukin 2: strategy and tactics. J Immunol 1983; 131: 1808–1815.
Kumagai, K, Itoh K, Suzuki R, Kinuma S, Saitoh F. Studies of murine large granular lymphocytes. I. Identification as effector cells in NK and K cytotoxicities. J Immunol 1982; 129: 388–894.
Gillis S, Ferm MM, Ou W, Smith KA. T cell growth factor: Parameters of production and a quantitative microassay for activity. J Immunol 1978; 120: 2027–2032.
Grimm EA, Mazumder A, Zhang HZ, Rosenberg SA. The lymphokine activated killer cell phenomenon: lysis of NK-resistant fresh solid tumor cells by IL-2 activated autologous human peripheral blood lymphocytes. J Exp Med 1982; 155: 1823–1841.
Grimm EA, Ramsey KM, Mazumder A, Wilson DJ, Djeu JY, Rosenberg SA. Lymphokine-activated killer cell phenomenon. II. Precursor phenotype is serologically distinct from peripheral T lymphocytes, memory cytotoxic thymus-derived lymphocytes and natural killer cells. J Exp Med 1983; 157: 887–897.
Owen-Schaub LB, Abraham SR, Hemstreet III GP. Phenotypic characterization of murine lymphokine-activated killer cells. Cell Immunol 1986; 103: 272–286.
Habu S, Fukui H, Shimamura K, Kasai M, Nagai Y, Okumura K, Tamaoki N.In vivo effects of antiasialo GM1. I. Reduction of NK activity and enhancement of transplanted tumor growth in nude mice. J Immunol 1981; 127: 34–38.
Kasai M, Yoneda S, Habu S, Murayama Y Okumura K, Tokunaga T.In vivo effect of anti-asialo GM1, antibody on natural killer activity. Nature 1981; 291: 334–335.
Suzuki R, Suzuki S, Ebina N, Kumagai K. Suppression of cells immuno cytotoxic T lymphocyte (CTC) generation by depression of NK cells and restoration by interferon and/or IL2. J Immunol 1985; 114: 2139–2148.
Karre K, Klein GO, Kiessling R, Klein G, Roder JC. Low naturalin vivo resistance to syngeneic leukemias in natural killer-deficient mice. Nature 1980; 284: 624–626.
Talmadge JE, Meyers KM, Prieur DJ, Starkey JR. Role of NK cells in tumor growth and metastasis in beige mice. Nature 1980; 284: 622–624.
Ono A, Amos DB, Koren HS. Selective cellular natural killing against human leukaemic T cells and thymus. Nature 1977; 266: 546–548.
Hansson M, Kiessling R, Anderson B, Karre K, Roder J. NK cell-sensitive T-cell subpopulation in thymus: inverse correlation to host NK activity. Nature 1979; 278: 174–176.
Nunn ME, Herberman RB, Holden HT. Natural cell-mediated cytotoxicity in mice against non-lymphoid tumor cells and some normal cells. Int J Cancer 1977; 20: 381–387.
Teh HS, Yu M. Activation of nonspecific killer cells by interleukin 2-containing supernatants. J Immunol 1983; 131: 1827–1833.
Rosenstein M, Yron I, Kaufmann Y, Rosenberg SA. Lymphokine-activated killer cells: lysis of fresh syngeneic natural killer-resistant murine tumor cells by lymphocytes cultured in interleukin 2. Cancer Res 1984; 44: 1946–1953.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ono, M., Tanaka, N. & Orita, K. The augmentation of lymphokine-activated killer cells induced by partial hepatectomy in mice. The Japanese Journal of Surgery 19, 726–737 (1989). https://doi.org/10.1007/BF02471724
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02471724